Similar Items: Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
- Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease
- Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
- Metabolic Dysfunction–Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations
- Mapping the Intellectual Landscape: A 20-Year Bibliometric Analysis of Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease
- Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)
- Impact of Smoking Cessation Attempts on Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Large Propensity Score–Matched Cohort Study